We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Virus Linked to Aggressive Breast Cancers

By Biotechdaily staff writers
Posted on 21 Jul 2004
Nearly three-quarters of a small sample of Tunisian breast cancer patients showed evidence of a virus similar to one known to cause breast cancer in mice, according to a study published in the July 12, 2004, issue of Cancer.

This is twice the rate seen in women in the United States. Although viruses are known to play a primary role in the development of several human cancers, such as the T cell lymphotropic virus and adult T cell leukemia/lymphoma or herpes virus 8 (HHV8) and Kaposi sarcoma (KS), geographic variability has been noted. For example, KS and HHV8 are least common in the United States and more common in the Mediterranean and Central African regions.

Previous analyses of human breast tissue found viral sequences from the mouse mammary tumor virus (MMTV) in a large percentage of breast cancers but not in normal tissue. MMTV may be spread by a species of house mouse very common in North Africa but not in the United States.

Researchers compared 38 breast tumors from Tunisian patients with samples from several other countries. A significantly higher proportion of samples from Tunisia tested positive for an MMTV-specific genetic sequence, compared to samples from North America. While 74% of Tunisian samples tested positive, other studies reported only 36% from the United States, 38% from Italy, 42% from Australia, and 31% from Argentina. Further analyses revealed that 89% of the MMTV-positive samples were from clinically and histologically aggressive tumors.

"These findings provide increasing evidence for a human breast cancer virus with geographic differences in prevalence,” concluded the authors. The study was conducted by Dr. Paul H. Levine from the George Washington University School of Public Health and Health Services (Washington, DC, USA; www.gwumc.edu) and his colleagues.





Related Links:
George Washington Univ. School of Public Health

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Thyroid Test
Anti-Thyroid EIA Test

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
21 Jul 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
21 Jul 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
21 Jul 2004  |   BioResearch